Morphology and immunohistochemistry for 2sc and fh aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients

American Journal of Surgical Pathology

Volumn 39, Issue 11, 2015, Pages 1529-1539

  Joseph, Nancy M ^a   Solomon, David A ^a   Frizzell, Norma ^b   Rabban, Joseph T ^a   Zaloudek, Charles ^a   Garg, Karuna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

2sc; Fumarate hydratase; Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC); Uterine smooth muscle tumors

Indexed keywords

CYSTEINE; FUMARATE HYDRATASE; S-(2-SUCCINYL)CYSTEINE; TUMOR MARKER;

ADULT; AGE; ANALOGS AND DERIVATIVES; BIOPSY; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; EVALUATION STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMATOSIS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; SKIN NEOPLASMS; UTERINE NEOPLASMS; YOUNG ADULT;

ADULT; AGE FACTORS; BIOMARKERS, TUMOR; BIOPSY; CYSTEINE; DNA MUTATIONAL ANALYSIS; FEMALE; FUMARATE HYDRATASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMATOSIS; MUTATION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SKIN NEOPLASMS; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84944145609     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000520     Document Type: Article

References (20)

1. Tomlinson IP, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30:406-410.
2. Alam NA, Rowan AJ, Wortham NC, et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet. 2003;12: 1241-1252.
3. Pollard PJ, Briere JJ, Alam NA, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet. 2005;14:2231-2239.
4. Sanz-Ortega J, Vocke C, Stratton P, et al. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol. 2013;37:74-80.
5. Lehtonen R, Kiuru M, Vanharanta S, et al. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol. 2004;164:17-22.
6. Chen YB, Brannon AR, Toubaji A, et al. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol. 2014;38:627-637.
7. Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003;73: 95-106.
8. Stewart L, Glenn GM, Stratton P, et al. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol. 2008;144:1584-1592.
9. Merino MJ, Torres-Cabala C, Pinto P, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31:1578-1585.
10. van Spaendonck-Zwarts KY, Badeloe S, Oosting SF, et al. Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: Implications for surveillance. Fam Cancer. 2012;11:123-129.
11. Udager AM, Alva A, Chen YB, et al. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC): A rapid autopsy report of metastatic renal cell carcinoma. Am J Surg Pathol. 2014;38: 567-577.
12. Reyes C, Karamurzin Y, Frizzell N, et al. Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)- cysteine immunohistochemistry. Mod Pathol. 2014;27:1020-1027.
13. Bardella C, El-Bahrawy M, Frizzell N, et al. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J Pathol. 2011;225:4-11.
14. Merino M, Stratton P, Linehan MW, et al. Fumarate Hydratase assist to recognize smooth muscle tumors associated with hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC). Mod Pathol. 2014;27(suppl 2):296A.
15. Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO Classification of Tumors of the Female Reproductive Organs, 4th ed. Lyon, France: IARC Press; 2014.
16. Talevich E, Shain AH, Botton T, et al. CNVkit: Copy number detection and visualization for targeted sequencing using off-target reads. bioRxiv. 2014. doi: http://dx.doi.org/10.1101/010876.
17. Gardie B, Remenieras A, Kattygnarath D, et al. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet. 2011;48:226-234.
18. Alsolami S, El-Bahrawy M, Kalloger SE, et al. Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas. Int J Gynecol Pathol. 2014;33:560-567.
19. Croce S, Young RH, Oliva E. Uterine leiomyomas with bizarre nuclei: A clinicopathologic study of 59 cases. Am J Surg Pathol. 2014;38:1330-1339.
20. Barker KT, Spendlove HE, Banu NS, et al. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett. 2006;235:136-140.